0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Investigation | 
Timothy R. Rebbeck, PhD; Nandita Mitra, PhD; Fei Wan, MS; et al.
JAMA. 2015;313(13):1347-1361. doi:10.1001/jama.2014.5985.
Includes: CME, Supplemental Content

Medical News & Perspectives | 
Kate O’Rourke
JAMA. 2014;312(3):218-219. doi:10.1001/jama.2014.7708.

Clinical Trials Update | 
Anita Slomski
JAMA. 2014;311(16):1602. doi:10.1001/jama.2014.4464.

JAMA Clinical Challenge | 
Barry Ladizinski, MD; Kachiu C. Lee, MD, MPH
JAMA. 2013;310(12):1281-1282. doi:10.1001/jama.2013.277797.

JAMA Clinical Challenge | 
Olubukola Olusade Okafor, MD, Msc; Jennifer Erin Crotty, MD
JAMA. 2013;309(17):1828-1829. doi:10.1001/jama.2013.3145.

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2012;308(22):2326. doi:10.1001/jama.2012.111747.

Medical News & Perspectives | 
Anita Slomski
JAMA. 2012;307(23):2474-2475. doi:10.1001/jama.2012.5646.

Clinical Crossroads | 
Panagiotis A. Konstantinopoulos, MD, PhD; Christopher S. Awtrey, MD
JAMA. 2012;307(13):1420-1429. doi:10.1001/jama.2012.269.
Includes: CME, Supplemental Content

Editorial | 
David M. Hyman, MD; David R. Spriggs, MD
JAMA. 2012;307(4):408-410. doi:10.1001/jama.2012.24.

Original Contribution |  FREE
Kelly L. Bolton, PhD; Georgia Chenevix- Trench, PhD; Cindy Goh, BA; et al.
JAMA. 2012;307(4):382-389. doi:10.1001/jama.2012.20.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Usefulness of Multigene Testing Catching the Train That’s Left the Station
Elizabeth M. Swisher, MD
JAMA Oncology
Original Investigation  | 
Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment
Andrea Desmond, BS; Allison W. Kurian, MD, MSc; Michele Gabree, MS, CGC; et al.
JAMA Oncology
Editorial  | 
Ovarian Cancer Survival and Chemotherapy Dosing, Body Mass Index, and Body Surface Area  Are We There Yet?
S. Percy Ivy, MD; Jan H. Beumer, PharmD, PhD
JAMA Oncology
Original Investigation  | 
Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index
Elisa V. Bandera, MD, PhD; Valerie S. Lee, MHS; Lorna Rodriguez-Rodriguez, MD, PhD; et al.